Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology
Authors
Keywords
-
Journal
Nature Communications
Volume 3, Issue 1, Pages -
Publisher
Springer Nature
Online
2012-09-25
DOI
10.1038/ncomms2032
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Alpha-Synuclein Oligomerization and Aggregation in Cellular and Animal Models of Parkinson’s Disease
- (2012) Oi Wan Wan et al. PLoS One
- Principles for the post-GWAS functional characterization of cancer risk loci
- (2011) Matthew L Freedman et al. NATURE GENETICS
- Regulatory impact factors: unraveling the transcriptional regulation of complex traits from expression data
- (2010) Antonio Reverter et al. BIOINFORMATICS
- Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1
- (2010) Frits Kamp et al. EMBO JOURNAL
- Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson’s disease pathogenesis
- (2010) Tiziana Alberio et al. FEBS Journal
- Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated α-synuclein gene mutations precede central nervous system changes
- (2010) Yien-Ming Kuo et al. HUMAN MOLECULAR GENETICS
- -Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
- (2010) J. Burre et al. SCIENCE
- PGC-1 , A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
- (2010) B. Zheng et al. Science Translational Medicine
- Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences
- (2010) Jeremy Goecks et al. GENOME BIOLOGY
- Genetic Control of Human Brain Transcript Expression in Alzheimer Disease
- (2009) Jennifer A. Webster et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
- (2009) Wataru Satake et al. NATURE GENETICS
- Genome-wide association study reveals genetic risk underlying Parkinson's disease
- (2009) Javier Simón-Sánchez et al. NATURE GENETICS
- Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons
- (2009) Eugene V. Mosharov et al. NEURON
- Repression of -synuclein expression and toxicity by microRNA-7
- (2009) E. Junn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Differential Wiring Analysis of Expression Data Correctly Identifies the Gene Containing the Causal Mutation
- (2009) Nicholas J. Hudson et al. PLoS Computational Biology
- Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
- (2009) Ben Langmead et al. GENOME BIOLOGY
- cis-acting sequences and trans-acting factors in the localization of mRNA for mitochondrial ribosomal proteins
- (2008) Annapina Russo et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Housekeeping while brain's storming Validation of normalizing factors for gene expression studies in a murine model of traumatic brain injury
- (2008) Hervé Rhinn et al. BMC MOLECULAR BIOLOGY
- Integrated Weighted Gene Co-expression Network Analysis with an Application to Chronic Fatigue Syndrome
- (2008) Angela P Presson et al. BMC Systems Biology
- Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain
- (2008) Latha Devi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Vienna RNA Websuite
- (2008) A. R. Gruber et al. NUCLEIC ACIDS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More